Between Dec 19, 2024 and Jan 2, 2025, datasets can be submitted to DRUM but will not be processed until after the break. Staff will not be available to answer email during this period, and will not be able to provide DOIs until after Jan 2. If you are in need of a DOI during this period, consider Dryad or OpenICPSR. Submission responses to the UDC may also be delayed during this time.
 

Mechanisms of Androgen-Mediated Repression of the Maspin Tumor Suppressor Gene in Prostate Cancer

2009-04-08
Loading...
Thumbnail Image

Persistent link to this item

Statistics
View Statistics

Journal Title

Journal ISSN

Volume Title

Title

Mechanisms of Androgen-Mediated Repression of the Maspin Tumor Suppressor Gene in Prostate Cancer

Published Date

2009-04-08

Publisher

Type

Presentation

Abstract

It is estimated that one in six men in North America will be diagnosed with prostate cancer (PCa) during his lifetime. Localized PCa is often treated using surgery and radiation. Advanced and metastatic PCa can be treated by blocking the production or action of androgens, the male sex hormones. This androgen depletion therapy is only temporarily successful because PCa frequently returns in an androgen-refractory form that is resistant to hormonal manipulations and capable of growing in an androgen-depleted environment. Androgen receptor (AR) is a nuclear receptor transcription factor necessary for normal prostate cell growth and function as well as for growth of PCa. Androgens activate the AR, which translocates to the nucleus where it transcriptionally activates or represses target genes. One such gene is the Maspin tumor suppressor. Maspin is a proteinase inhibitor that serves to prevent proteinase degradation of the extracellular matrix, which is prerequisite to tumor invasion and metastasis. Androgens transcriptionally repress Maspin, but the mechanisms have not yet been fully characterized. To investigate the mechanisms of Maspin repression, a plasmid containing the luciferase reporter gene under the control of the Maspin promoter was constructed and transfected into VCaP and LNCaP PCa cell lines. Transfected cells were treated with dihydrotestosterone (a natural androgen) or mibolerone (a synthetic androgen) for 24 hours. Luciferase activity was subsequently measured by dual luciferase assay. These experiments have indicated that the AR may not directly repress Maspin transcription. Ongoing research will utilize real time PCR to determine whether AR inhibits Maspin transcription via a direct or indirect mechanism.

Description

Additional contributor: Scott M. Dehm (faculty mentor).

Related to

Replaces

License

Series/Report Number

Funding information

This research was supported by the Undergraduate Research Opportunities Program (UROP).

Isbn identifier

Doi identifier

Previously Published Citation

Other identifiers

Suggested citation

Bader, David. (2009). Mechanisms of Androgen-Mediated Repression of the Maspin Tumor Suppressor Gene in Prostate Cancer. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/50314.

Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.